Skip to content

Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease)

Sleep Quality in COPD Patients. A Clinical and Polysomnographic Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03290014
Acronym
COPD
Enrollment
58
Registered
2017-09-21
Start date
2017-03-01
Completion date
2018-09-30
Last updated
2017-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

Patients with COPD, in addition to daytime symptoms, may suffer from nocturnal disturbances. The frequency of nocturnal problems has been reported to be higher in COPD than in the general population and it currently affects up to 50% of patients. The CASIS questionnaire includes 7 questions and it has been recently validated as an objective tool to evaluate nocturnal symptoms in patients with asthma and COPD. The present study aims to study the validity of the CASIS questionnaire as a predictor of sleep quality measured by objective polysomnographic parameters.

Interventions

DIAGNOSTIC_TESTpolysomnography

Monitoring of brain activity and respiratory variables during sleep

DIAGNOSTIC_TESTActigraphy

monitoring daily physical activity for 7 days

DIAGNOSTIC_TESTOsler test

Evaluation of subjects´ ability to remain awake

Sponsors

AstraZeneca
CollaboratorINDUSTRY
Hospital Universitari Vall d'Hebron Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients with written inform consent to participate in the study and all the following criteria will be selected: * Age 40-80 years * Smokers or exsmokers of at least 10 pack-years * Moderate-to-severe COPD

Exclusion criteria

* Non-stable COPD. Stability is defined as being exacerbation free and without treatment changes for at least 4 weeks prior to baseline evaluation. The presence of a COPD exacerbation previous to the sleep studies (polysomnography, actigraphy, OSLER test) will lead to an early discontinuation of the patient´s participation in the study. * Heart failure, asthma, cancer or other major medical illness with known effects on sleep quality. * Unable to understanding the questionnaires administered in the study. * Known Obstructive Sleep Apnea, other sleep disorder (narcolepsy, periodic limb movements) or shift work. * Chronic respiratory failure (PaO2 \<60 mmHg). * Treatment with sedatives or antidepressants.

Design outcomes

Primary

MeasureTime frameDescription
Sleep efficiencyOne night at the sleep unitSleep time/Time in bed

Secondary

MeasureTime frameDescription
Total sleep timeOne night at the sleep unitTotal sleep time
Arousal indexOne night at the sleep unitnumber of arousals/hour of sleep
sleep architectureOne night at the sleep unitpercentage of the different sleep phases
Osler test error indexNext morning after polysomnography (8a.m.--4 p.m.)number of errors
ActigraphyOne week previous to polysomnographyMonitoring of rest/activity cycles

Countries

Spain

Contacts

Primary ContactGabriel Sampol, PhD
gsampol@vhebron.net+34932746083
Backup ContactJaume Ferrer, PhD
jjferrer@vhebron.net+34932746083

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026